Medtronic

MDT | NYSE

Price Alert Chart Builder DCF Calculator

$96.54

-$0.57 (-0.59%)

At close: Oct 30, 2026, 4:00 PM ET

$96.44

-$0.10 (-0.10%)

Pre-market: Nov 2, 2026, 4:03 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $123.49B

Enterprise Value $149.85B

Beta 0.57

Average Volume 14.01M

Shares Outstanding (Diluted) 1.29B

Shares Change YoY -0.16%

Institutional Ownership 86.10%

Exchange NYSE

ISIN IE00BTN1Y115

Price Performance

Price Change 1M 11.9%

Price Change 3M 13.1%

Price Change 6M 20.7%

Price Change YTD 0.5%

Price Change 1Y 6.4%

Price Change 3Y 36.8%

Price Change 5Y -19.5%

1M CAGR (ann.) 5.7%

1Y CAGR (ann.) 8.7%

5Y CAGR (ann.) -1.6%

All-Time CAGR 4.5%

Valuation

PE Ratio 23.78

Forward PE 16.13

PEG Ratio 1.86

Forward PEG 2.84

PS Ratio 3.29

Forward PS 3.20

PB Ratio 2.46

P/FCF Ratio 20.14

P/Adj. FCF Ratio 21.91

P/OCF Ratio 15.37

EV/Sales 3.99

EV/EBIT 20.45

EV/EBITDA 15.86

EV/FCF 24.44

Earnings Yield 4.2%

FCF Yield 5.0%

Adj. FCF Yield 4.6%

Financial Health

Net Debt $26.36B

Total Debt $28.15B

Cash & Short-Term Investments $1.79B

Total Assets $93.31B

Current Ratio 2.07

Quick Ratio 2.09

Debt / Equity Ratio 0.56

Debt / EBITDA 2.98

Debt / FCF 4.59

OCF / Debt 0.29

Interest Coverage 9.36

Altman Z-Score 3.08

Piotroski F-Score 8

Margins & Profitability

Gross Profit Margin 66.7%

Operating Profit Margin 18.1%

EBITDA Margin 27.1%

Net Profit Margin 13.9%

FCF Margin 16.3%

Adj. FCF Margin 15.0%

SBC / Revenue 1.3%

SBC Impact (per share) -8.1%

Returns

Return on Assets 5.6%

Return on Equity 10.6%

Return on Invested Capital 6.4%

Return on Capital Employed 8.3%

Return on Tangible Assets 13.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 6.0%

Revenue CAGR 5Y 3.5%

Revenue CAGR 10Y 2.7%

EPS CAGR 3Y 14.4%

EPS CAGR 5Y 7.3%

EPS CAGR 10Y 4.7%

FCF CAGR 3Y 11.3%

FCF CAGR 5Y 0.9%

FCF CAGR 10Y 2.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 22

EPS Growth Next 3Y 19.1%

Revenue Growth Next 3Y 3.9%

Earnings Date Nov 17, 2026

EPS Estimate (next Q) $1.33

EPS Growth Est (next Q) -2.2%

Revenue Est (next Q) $9.48B

Revenue Growth Est (next Q) 5.8%

Fair Value Estimates

Graham Number $60.24

Graham Upside -37.6%

Lynch Fair Value $29.48

Lynch Upside -69.5%

Price Target $97.73

Price Target Upside 1.2%

Cash Flow

Operating Cash Flow $8.04B

Free Cash Flow $6.13B

Adj. Free Cash Flow $5.64B

FCF Per Share $4.79

OCF Per Share $6.28

OCF/S Ratio 21.4%

Income Statement

Revenue $37.54B

Gross Profit $25.04B

Operating Income $6.79B

EBITDA $9.45B

Net Income $5.23B

EPS (Diluted) $4.06

Revenue / Employee $395.18K

Profit / Employee $55.05K

Employees 95,000

Dividends

Annual Dividend $2.86

Dividend Yield 2.96%

Payout Ratio 70.4%

FCF Payout Ratio 59.5%

Adj. FCF Payout Ratio 64.8%

Dividend Growth (YoY) 1.4%

Pay Frequency Quarterly

Ex-Dividend Date Sep 25, 2026